{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEPO-21018  Vancomycin resistant enterococci (VRE) policy 1.0.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 15,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title"
                    },
                    {
                        "text": "VANCOMYCIN RESISTANT ENTEROCOCCI (VRE) POLICY"
                    },
                    {
                        "text": "Document Reference/Register no:"
                    },
                    {
                        "text": "MSEPO-21018"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: Policy"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All staff"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "06 April 2021"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "05 April 2024"
                    },
                    {
                        "text": "Developed in response to:"
                    },
                    {
                        "text": "DH (2010) The Health and Social Care Act 2008: code of practice for health and adult social care on the prevention and control of infections and related guidance"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Harm Free Care"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Emma Dowling Head of Nursing Infection Prevention and Control MSE"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box/es to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2610 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "Basildon Hospital IPCC Broomfield Hospital IPCC Southend Hospital IPCC"
                    },
                    {
                        "text": "05 March 2021"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "Dawn Patience Director Harm Free Care"
                    },
                    {
                        "text": "05 March 2021"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "06 April 2021"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Document Ratification Group)"
                    },
                    {
                        "text": "May 21"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612Trust Intranet \u2612Internet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSEPO-21018  Vancomycin resistant enterococci (VRE) policy 1.0.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 9,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Consulted With: this must include Pharmacy if the document has any reference to medication"
                    },
                    {
                        "text": "Post/ Approval Committee/ Group:"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Edith Mahachi"
                    },
                    {
                        "text": "Site Lead Nurse Infection Control Basildon"
                    },
                    {
                        "text": "05 March 2021"
                    },
                    {
                        "text": "Judy Holdsworth"
                    },
                    {
                        "text": "Site Lead Nurse Infection Control Broomfield"
                    },
                    {
                        "text": "05 March 2021"
                    },
                    {
                        "text": "Dr Awad-El-Kariem"
                    },
                    {
                        "text": "Consultant Microbiologist /DIPC Basildon"
                    },
                    {
                        "text": "05 March 2021"
                    },
                    {
                        "text": "Dr John Day"
                    },
                    {
                        "text": "Consultant Infectious Diseases/Infection Control Doctor Southend"
                    },
                    {
                        "text": "05 March 2021"
                    },
                    {
                        "text": "Titi Odewumi"
                    },
                    {
                        "text": "Lead Antimicrobial Pharmacist MSE"
                    },
                    {
                        "text": "05 March 2021"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Infection Control Committee Southend"
                    },
                    {
                        "text": "05 March 2021"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Infection Control Committee Basildon"
                    },
                    {
                        "text": "05 March 2021"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Infection Control Committee Broomfield"
                    },
                    {
                        "text": "05 March 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "Decontamination Policy Isolation Policy MSEPO-20215 Hand Hygiene Outbreak Policy Empiric Antibiotic Guidelines for Critical Care Patients Adults Empiric Antibiotic Guidelines for the Accident and Emergency Dept. Empiric Antibiotic Guidelines for Paediatric Patients Empiric Antimicrobial Guidelines for Obstetrics & Gynaecology"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Emma Dowling"
                    },
                    {
                        "text": "Newly created MSE Document. Supersedes: IC012 Glycopeptide Resistant Enterococci (GRE) and Vancomycin Resistant Enterococci (VRE) Policies. 08028 (GRE) Glucopeptide Resistant Enterococci."
                    },
                    {
                        "text": "06 April 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 7
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction .................................................................................................................. 4"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Definitions .................................................................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Role & Responsibilities within the Trust ....................................................................... 4"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Risk Factors and Transmission of GRE/VRE ............................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Surveillance and screening .......................................................................................... 6"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Procedures required for managing VRE ...................................................................... 6"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Training Requirements ................................................................................................. 8"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Monitoring and Audit .................................................................................................... 9  Approval and Implementation....................................................................................... 9  Equality Impact Assessment ........................................................................................ 9  References ................................................................................................................... 9 Appendix 1: Preliminary Equality Analysis ........................................................................ 11"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "Enterococci  are  an  increasingly  common  cause  of  healthcare  associated infection. Infections caused by Vancomycin Resistant Enterococci (VRE) that become resistant to both Vancomycin and Teicoplanin they are known as Glycopeptide Resistant Enterococci (GRE). The infection control principles for"
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 0,
                "text": "individual cases or when there are clusters are the same for VRE and GRE therefore for the purposes of this policy the term VRE will be used."
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "This policy aims to guide staff in the safe management of patients who have laboratory proven or clinically suspected VRE infection and/or colonisation, in order to prevent transmission of infection"
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "type": "table",
            "sequence_num": 23,
            "data": {
                "num_rows": 9,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERMS"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "DIPC"
                    },
                    {
                        "text": "Director of Infection Prevention and Control"
                    },
                    {
                        "text": "GRE"
                    },
                    {
                        "text": "Glycopeptide-resistant Enterococci."
                    },
                    {
                        "text": "ITU"
                    },
                    {
                        "text": "Intensive Therapy Unit"
                    },
                    {
                        "text": "IPCC"
                    },
                    {
                        "text": "Infection Prevention and Control Committee."
                    },
                    {
                        "text": "IPCN"
                    },
                    {
                        "text": "Infection Prevention and Control Nurse"
                    },
                    {
                        "text": "IPCT"
                    },
                    {
                        "text": "Infection Prevention and Control Team"
                    },
                    {
                        "text": "MSE"
                    },
                    {
                        "text": "Mid and South Essex Foundation Trust"
                    },
                    {
                        "text": "VRE"
                    },
                    {
                        "text": "Vancomycin resistant Enterococci"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Role & Responsibilities within the Trust"
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "Infection Prevention and Control Committee (IPCC) is responsible for the review of this policy at least every two years, but more frequently if there are changes to Infection Prevention and Control Legislation or guidance"
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "The Chief Executive has overall responsibility for ensuring the Trust has the necessary  management  systems  in  place  to  enable  the  effective implementation  of this  policy  and  overall  responsibility  for  the  health  and safety of staff, patients and visitors"
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.3,
                "text": "The  Director  for  Infection  Prevention  and  Control  (DIPC)  will  have operational responsibility for the effective implementation of this policy"
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.4,
                "text": "The Head of Nursing for Infection Prevention and Control"
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Oversee infection control policies and their implementation"
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Responsible for infection prevention and control teams across the MSE"
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reports directly to the Head of Harm Free Care"
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Challenge inappropriate hygiene practice and antibiotic prescribing"
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Assess impact of plans/policies on infection prevention and control"
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Member of clinical governance structures"
            },
            "type": "ListItem",
            "sequence_num": 34
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.5,
                "text": "The Infection Prevention and Control Teams (IPCT) are responsible for ensuring all staff are made aware of this policy and advising ward staff on control measures, providing them with the necessary advice"
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.6,
                "text": "Microbiology Department"
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The microbiology laboratory and Consultant microbiologists are responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that appropriate tests are available for identification of VRE"
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that results are communicated promptly to clinical teams"
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Providing timely advice to clinicians regarding appropriate treatment, where relevant"
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Monitoring the use of antimicrobial agents within the Trust and feedback on areas for improvement"
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.7,
                "text": "Clinical Site Management Team"
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The Clinical Site Management team are responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Assisting ward staff to identify single room accommodation for patients with VRE where risk assessment has shown that this is appropriate."
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.8,
                "text": "All Staff must comply with this policy and act in a responsible manner, liaising with the IPCT in a timely manner if in need of advice or support. All staff have a responsibility to ensure that infection prevention and control is embedded into their everyday practice and applied consistently at all times"
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Risk Factors and Transmission of GRE/VRE"
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Enterococci (Enterococcus species) are a group of bacteria naturally present in the intestinal tract of humans and normally cause no harm (colonisation). However sometimes enterococci can cause infections in wounds, urine and in more serious infections in blood. Most infections are caused by the patient's own bacteria but cross-infection between patients in hospital can happen."
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "VRE are enterococci that are resistant to an antibiotic called Vancomycin. VRE are often resistant to other types of antibiotics"
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.3,
                "text": "Colonisation  is the presence, growth and multiplication of the bacteria without observable signs or symptoms of infections."
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.4,
                "text": "Infections refer to invasion of the bacteria into the patient tissues with signs or symptoms of infection/illness."
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.5,
                "text": "Most  Enterococci  infections, including VRE are endogenous but cross infection between patients can occur as follows:"
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Transmission via environmental contamination"
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Healthcare workers hands"
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Direct patient to patient contact"
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Equipment such as thermometers, commodes"
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.6,
                "text": "Those patients at high risk of acquiring VRE colonisation/infection are:"
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Critically ill patients"
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patients with severe underlying disease or immuno-suppression such as patients in Critical Care Units and Oncology Departments."
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patients who have had intra-abdominal or surgical procedures"
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patients with permanent indwelling urinary catheters"
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patients with a prolonged hospital stay"
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patients who have had multi-antimicrobial and/or Vancomycin therapy"
            },
            "type": "ListItem",
            "sequence_num": 62
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Underlying disease especially hepatobiliary disease"
            },
            "type": "ListItem",
            "sequence_num": 63
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patients  with  permanent  indwelling  percutaneous  endoscopic gastroscopy tubes"
            },
            "type": "ListItem",
            "sequence_num": 64
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Surveillance and screening"
            },
            "type": "ListItem",
            "sequence_num": 65
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "Routine  trust-wide  admission  screening  is  currently  not  recommended. However, selective admission and/or interval screening on high risk groups may be undertaken on advice of infection control service."
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.2,
                "text": "Screening during suspected outbreaks and in response to important incidents will be at request of Infection Control Doctor/Consultant Microbiologist."
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Procedures required for managing VRE"
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.1,
                "text": "Isolation"
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.1.1 Patients  should  be  risk  assessed  for  the  need  for  isolation.  If  deemed necessary a side room facility preferably with an en-suite toilet facility should be requested, if there is no en-suite toilet facility, a commode should be dedicated for use only by the patient."
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.1.2 Gloves  and  aprons  must  be  worn  by  staff  for  direct  patient  contact  and cleaning  the  environment.  Protective  clothing  must  be  removed  prior  to leaving the room."
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.1.3 It is unnecessary to wear protective clothing for activities that do not involve significant patient or environmental contact, e.g. giving oral medication."
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.1.4 Hands must be washed immediately after glove removal"
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.1.5 The door should be left closed whenever possible and must be kept closed during all procedures."
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.1.6 A \u2018Standard Precaution' notice should be placed on the outside of the door."
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.1.7 Patients receiving renal dialysis to be dialysed in a single room"
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 1,
                "text": "7.1.8 Long sleeved gowns and masks are not required"
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.1.9 Dedicated equipment must be used and wherever possible disposable/single use."
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.1.10 Non-disposable equipment (e.g. stethoscopes, lifting slings) that is required for care, must be decontaminated upon leaving the room (refer to the Decontamination Policy), or preferably designated for the patient's sole use during their hospital stay."
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.2,
                "text": "Commode/Toilet Hygiene"
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.2.1 It is important that commode chairs are cleaned after every use. This is because they may become contaminated or be contaminated and cross infection will occur."
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.2.2 The commode should be cleaned with a detergent wipe, and then cleaned with a solution of DIFFX /or Tristel jet spray in order to ensure that it is decontaminated and stored as clean i.e. with the commode arms out and the seat up turned."
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.2.3 The toilet must be kept clean and free from faecal deposits, as cross infection may occur via this route. Any contamination must be reported immediately and action taken to clean the area as soon as possible."
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.3,
                "text": "Linen and Waste Disposal"
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.3.1 All soiled linen must be placed in a pink alginate bag prior to placing into a white plastic laundry bag for laundering."
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.3.2 All other soiled waste should be disposed of into an orange clinical waste bag"
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.4,
                "text": "Hand Decontamination"
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.4.1 Hands should be decontaminated using soap and water or hand sanitiser before and after every contact with the patient, their immediate environment and their equipment"
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.4.2 Patients must be offered hand washing facilities after using the toilet or commode and before eating."
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.5,
                "text": "Room Cleaning"
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.5.1 Daily cleaning should take place with a solution of DiffX, paying particular attention to high touch points such as door handles, by the Ward Domestic"
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.5.2 Once a patient has been discharged, the room should undergo a terminal clean"
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.6,
                "text": "Treatment"
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.6.1  Antibiotic treatment will be advised on an individual patient basis by the Consultant Microbiologist."
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.7,
                "text": "Transfers"
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.7.1  Transfers of patients to other wards/departments/Trusts should be kept to a minimum unless necessary for clinical care. In such a case, the receiving ward/department should be informed by the nurse in charge of the ward/department transferring the patient, prior to transfer."
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.8,
                "text": "Visitors"
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.8.1 Nursing staff must inform the patient/next of kin of the reason for the isolation precautions being taken, and then contact the IPCT in order that an Infection Control Nurse can attend the ward to explain the VRE to the patient/next of kin."
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.8.2 Family and friends of the patient must be advised on hand washing when leaving the isolation room."
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.8.3 Gloves and apron are only required for use when giving direct care."
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.9,
                "text": "Outbreak Management"
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.9.1  If an outbreak of VRE infection/colonisation is suspected a number of actions to assist with the investigation and control of the incident will need to be undertaken as per Outbreak Policy. The IPCT will advise"
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.1,
                "text": "Death"
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 0,
                "text": "7.10.1  Infection Control precautions apply to deceased patients as in life. No specific precautions are required if the patient has VRE when they die."
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Training Requirements"
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "All Trust staff to undertake Mandatory Infection Prevention and Control updates and Donning and Doffing updates. The IPCT has primary responsibility for providing training on the policy where needed. Managers have the responsibly to support the IPCT by ensuring that staff are able to attend training sessions in response to identified needs."
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Monitoring and Audit"
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.1,
                "text": "Outlined below is the Trust's process of monitoring compliance with, and the effectiveness of the document's main points."
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "type": "table",
            "sequence_num": 109,
            "data": {
                "num_rows": 2,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group/Committee/forum which will receive the findings/monitoring report"
                    },
                    {
                        "text": "Committee/indivi dual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "Knowledge / compliance/ practice"
                    },
                    {
                        "text": "Audit"
                    },
                    {
                        "text": "Infection Prevention and Control Team"
                    },
                    {
                        "text": "Yearly"
                    },
                    {
                        "text": "IPCC"
                    },
                    {
                        "text": "IPPC"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Approval and Implementation"
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "All policies, procedures and guidelines will be approved by the MSE IPCC's with the authority to approve MSE policies. These will then be forwarded to the  Document  control  team  for  submission  and  ratification  by  the  Joint Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "It is the author's responsibility to inform the Director of Harm Free Care of the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Equality Impact Assessment"
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "(Refer to appendix 1)  References"
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Chadwick, P., Chadwick., Oppenheim, B., 1996. A report of a meeting on the epidemiology  and  control  of  glycopeptide-resistant  enterococci.  Journal  of Hospital Infection, 33(2), pp83-92."
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Department of Health and Social Care (2015). The Health and Social Care Act 2008: Code of practice on the prevention and control of infections. London. Department of Health. Available at: www.gov.uk/government/publications/the- health-and-social-care-act-2008-code-of-practice-on-the-prevention-and- control-of-infections-and-related-guidance."
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Grabsch, E., Mahony, A., Cameron, D. et al, 2012. Significant reduction in vancomycin-resistant enterococcus colonization and bacteraemia after introduction of a bleach-based cleaning-disinfection programme. Journal of Hospital Infection, 82(4), pp234-242."
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Hocquet, D., Muller, A., Bertrand, X., 2016. What happens in hospitals does not stay in hospitals: antibiotic-resistant bacteria in hospital wastewater systems. Journal of Hospital Infection, 93(4), pp395-402.."
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2013.0,
                "text": "Karki, S., Land, G., Atichison, S. et al,  Long-term carriage of vancomycin-resistant enterococci in patients discharged from hospitals: a 12\u2013 year retrospective cohort study. Journal of Clinical Microbiology, 51(10), pp3374-3379."
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 0,
                "text": "McGowan, J., 2004. Debate guidelines for control of glycopeptide-resistant enterococci (GRE) have not yet worked. Journal of Hospital Infection, 57(4), pp281-284."
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2016.0,
                "text": "Whelton, E., Lynch, C., O'Reilly, B. et al,  Vancomycin-resistant enterococci carriage in an acute Irish hospital. Journal of Hospital Infection, 93(2),  pp175-180."
            },
            "type": "ListItem",
            "sequence_num": 122
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Vancomycin resistant enterococci (VRE) policy / MSEPO-21018 /1.0"
            },
            "type": "ListItem",
            "sequence_num": 123
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Vancomycin resistant enterococci (VRE) policy / MSEPO-21018 /1.0"
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: Preliminary Equality Analysis"
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to Vancomycin resistant enterococci (VRE) policy / MSEPO-21018: (please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "type": "table",
            "sequence_num": 128,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2612 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 129,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "Standardisation of existing policies"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "To have one MSE Policy"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Staff and patients"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 & 2"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 130,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Emma Dowling"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Head of Infection Prevention and Control MSE"
                    },
                    {
                        "text": "23 March 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "If you have identified any negative impact in the preliminary analysis above, please request and complete the full Equality Impact Assessment (EIA) from Document Control."
            },
            "type": "ListItem",
            "sequence_num": 131
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 132
        }
    ]
}